AmplifyBio Selects Apprentice.io’s Tempo Manufacturing Execution System to Supercharge Manufacturing Capabilities as They Expand Capacity

WEST JEFFERSON, Ohio, November 7, 2023 (Newswire.com) – AmplifyBio, a leading service provider in discovery, safety, and manufacturing services for the development of advanced therapies, has chosen Apprentice.io’s cutting-edge Tempo Manufacturing Execution System (MES) to expand production capabilities and meet the increasing demand for modern modality commercialization on shorter de-risked timelines. Apprentice’s, no-code, fully cloud-native MES is equipped with the power and flexibility necessary to drive the development of cell, gene, and mRNA therapies, giving AmpifyBio clients a critical tool to increase production efficiency while protecting the quality and data integrity of their products.

The Tempo MES further offers a novel configuration that integrates mobile tablets and voice-controlled wearable headsets and is a big step forward in integrating global teams to operate in real time. That seamless connection of remote teams makes the system ideal for AmplifyBio, which offers manufacturing services in varied staffing models that allow client development teams to be hands-on and fully integrate with AmplifyBio experts and support staff throughout manufacturing scale-up. Collaborating closely with the Apprentice professional services team, the AmplifyBio group achieved a swift implementation and validation of the Apprentice Tempo solution in a record-setting period of fewer than four months. This remarkable achievement equips AmplifyBio and its clientele with the capacity to effortlessly adapt to evolving processes while eliminating the necessity for extensive batch process re-engineering. Key features of this groundbreaking implementation include simultaneous access to process data from multiple locations and a streamlined data exchange system throughout the manufacturing process, enhancing operational efficiency and flexibility.

“AmplifyBio’s decision to choose Apprentice’s Manufacturing Execution System shows our commitment to introduce modern, flexible, and scalable manufacturing processes that accelerate end-to-end production and supercharge our data-centric journey,” said Karim Khoury, VP of Information Systems at AmplifyBio. “As we rapidly increase our capacity to offer manufacturing suites in hoteling business models, hybrid team models, and full partnership models, it’s critical to ensure that those novel approaches to staffing are paired with the right technology solutions and like-minded partners to uphold timelines and quality standards, and critically, much earlier in the development process than is typical.”

Since its inception, AmplifyBio set a strategic mission to create a paperless, technology-integrated drug development environment offering fully customizable service programs. With the adoption of Apprentice’s Tempo MES, they are embracing modern manufacturing practices critical to accelerating the development of modern therapeutics for patients waiting for them.

Manufacturing at AmplifyBio

Plasmid Manufacturing

Non Viral Gene Editing

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest